[HTML][HTML] Evidence and Value: Impact on DEcisionMaking–the EVIDEM framework and potential applications

MM Goetghebeur, M Wagner, H Khoury… - BMC health services …, 2008 - Springer
Background Healthcare decisionmaking is a complex process relying on disparate types of
evidence and value judgments. Our objectives for this study were to develop a practical …

Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada

FM Clement, A Harris, JJ Li, K Yong, KM Lee… - Jama, 2009 - jamanetwork.com
Context National public insurance for drugs is often based on evidence of comparative
effectiveness and cost-effectiveness. This study describes how that evidence has been used …

Facts, fallacies, and politics of comparative effectiveness research: Part 2-implications for interventional pain management

L Manchikanti, F Falco, MV Boswell… - Pain physician, 2010 - search.proquest.com
Abstract The United States leads the world in many measures of health care innovation.
However, it has been criticized to lag behind many developed nations in important health …

Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA) applying the EVIDEM framework …

MM Goetghebeur, M Wagner, H Khoury… - Medical decision …, 2012 - journals.sagepub.com
Background. Health care decision making is complex and requires efficient and explicit
processes to ensure transparency and consistency of factors considered. Objectives. To pilot …

[HTML][HTML] Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for …

MM Goetghebeur, M Wagner, H Khoury… - Cost Effectiveness and …, 2010 - Springer
Objectives To test and further develop a healthcare policy and clinical decision support
framework using growth hormone (GH) for Turner syndrome (TS) as a complex case study …

Health technology reassessment: the art of the possible

G MacKean, T Noseworthy, AG Elshaug… - International journal of …, 2013 - cambridge.org
Background: Health technology reassessment (HTR) is “a structured, evidence-based
assessment of the clinical, social, ethical, and economic effects of a technology currently …

[HTML][HTML] A prescription for improving drug formulary decision making

GD Schiff, WL Galanter, J Duhig, MJ Koronkowski… - PLoS …, 2012 - journals.plos.org
A Prescription for Improving Drug Formulary Decision Making | PLOS Medicine Skip to main
content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues …

[HTML][HTML] A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer

NA Nixon, MB Hannouf, S Verma - European Journal of Cancer, 2018 - Elsevier
The cost of cancer drugs continues to escalate with the rapid development and approval of
novel therapies, especially over the course of the last decade. In human epidermal growth …

Common Drug Review recommendations: an evidence base for expectations?

A Rocchi, E Miller, RB Hopkins, R Goeree - Pharmacoeconomics, 2012 - Springer
Abstract Background: The Common Drug Review (CDR) was created to provide a single
process to review the comparative clinical efficacy and cost effectiveness of new drugs, and …

International comparison of comparative effectiveness research in five jurisdictions: insights for the US

AR Levy, C Mitton, KM Johnston, B Harrigan… - …, 2010 - Springer
Spurred by a desire to improve quality of care and to understand the relative value of
medical treatments, there has been a recent surge of interest in publicly funded comparative …